Stock Analysts’ Updated EPS Estimates for August 3rd (CCEC, CRWV, INTU, NBIS, NBIX, PHAR, SYF, TFSL, TROW, WTW)

Stock Analysts’ updated eps estimates for Monday, August 3rd:

Capital Clean Energy Carriers (NASDAQ:CCEC) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a $23.00 target price on the stock.

Piper Sandler assumed coverage on shares of CoreWeave (NASDAQ:CRWV). They issued an overweight rating and a $151.00 price target on the stock.

Intuit (NASDAQ:INTU) had its hold rating reiterated by analysts at Truist Financial Corporation. The firm currently has a $350.00 price target on the stock, down from their previous price target of $410.00.

Piper Sandler initiated coverage on shares of Nebius Group (NASDAQ:NBIS). The firm issued a neutral rating and a $224.00 price target on the stock.

Neurocrine Biosciences (NASDAQ:NBIX) had its target price raised by Canaccord Genuity Group Inc. from $200.00 to $210.00. They currently have a buy rating on the stock.

Pharming Group (NASDAQ:PHAR) had its target price increased by Canaccord Genuity Group Inc. from $37.00 to $38.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.

Synchrony Financial (NYSE:SYF) had its target price boosted by UBS Group AG from $84.00 to $87.00. UBS Group AG currently has a neutral rating on the stock.

TFS Financial (NASDAQ:TFSL) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $18.00 target price on the stock, up from their previous target price of $16.00.

T. Rowe Price Group (NASDAQ:TROW) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. They currently have a $115.00 price target on the stock, down from their previous price target of $120.00.

Unity Software (NYSE:U) had its target price boosted by UBS Group AG from $28.00 to $32.00. They currently have a neutral rating on the stock.

Willis Towers Watson Public (NASDAQ:WTW) had its target price increased by UBS Group AG from $382.00 to $405.00. The firm currently has a buy rating on the stock.